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We have shown that the amyloid fibrilization of Ab16-22 follows
a reverse hofmeister trend in pILs. Fast fibrilization rates of
seconds can be achieved.
The self assembly and subsequent amyloid fibril formation of
proteins has implications in many human diseases, including
Alzheimer’s disease.1,2 The pathogenesis of Alzheimer’s disease
involves the self assembly of Ab monomers into dimers,
multimers and oligomers.1,3 The oligomers self assemble into
higher order aggregates termed protofilaments which continue
to grow into fibrils.4 The processes of Ab peptide assembly
from monomers to oligomers and into fibrils, and their
associated neurotoxicity is still an active area of research.5–8
Currently the neurotoxic species in the amyloid fibril assembling
process is thought to be some form of soluble oligomer, most
likely those that form during the early stages of Ab
aggregation.7,9,10 Recent trends have been directed at finding
strategies to control the Ab assembly process to allow
characterization of the early state oligomers.9,11,12 In addition
to developing methods to trap the early state oligomers, the
development of drugs specifically targeted at early stage Ab
aggregation are currently under investigation.12
Solvents can play a key role in controlling the fibrilization of
Ab,13,14 as such, various solvents and additives have been used
to study to Ab amyloid fibrilization. Ionic liquids are designer
solvents comprised entirely of ions. The advantages of ionic
liquids as solvents include low volatility, recyclability, excellent
solvating properties, variable polarity and a tremendous selection
of cation and anion combinations.15,16 Since the formation of
amyloid fibrils proceeds via the formation of intramolecular
hydrogen bonds we sort to use protic ionic liquids to manipulate
the hydrogen bond nature of the solvent to better control
amyloid fibril formation. The use of Ionic liquids as solvents
for biological applications is currently receiving considerable
attention, and ionic liquids have been used successfully as
refolding additives for protein renaturing studies,17,18
increased protein shelf life,19 enhanced thermal stability20,21
and as additives which increase enzymatic reaction rates.22
Recently pILs where shown to both promote and
inhibit amyloid fibrilization of hen egg white lyszyme.23,24
Hwang et al. also reported the ability of 1-Butyl-3-methylimidazolium
bis(trifluoromethylsulfonyl)imide to accelerate the fibrilization
of a-synuclein.25 Therefore, the characterization of ionic liquid
solvents and the impact they have on amyloid fibrilization is
important, especially since ionic liquids potentially have an
important role to play in furthering our knowledge of the
amyloid fibrilization process and in drug design. In this
context, our aim was to study the influence pILs have on the
amyloid fibrilization of the Ab16-22 peptide. This fragment
has been previously identified as a core fragment for amyloid
fibril formation in full length Ab,26,27 making this fragment an
appropriate peptide sequence to further our understanding of
the role ionic liquids can play in amyloid fibrilization.
We have used a combination of ThT fluorescence intensity,
circular dichroism, and transmission electron microcopy to
analyze and characterize the amyloid fibrilization of the Ab16-22
peptide using protic ionic liquid solvents.
The kinetics of amyloid fibrilization can be measured using
the ThT binding assay. ThT fluorescence intensity is sensitive
to beta sheet structure, with an increase in the fluorescence
intensity being measured when aggregation have proceeded to
the organized amyloid stage. Fig. 1 shows the ThT intensity
kinetics of the Ab16-22, in a series of different pILs with the
common cation triethylammonium, (Tea). pILs investigated in
Fig. 1 ThT intensity as a function of time for Ab16-22 in 90%
TeaHSO4 (red curve), 90% TeaH2PO4 (blue line), 90% TeaTFac
(green line), 90% TeaLa (purple line), 90% TeaTf (light blue line),
90% TeaMs (orange line) and phosphate buffer (black line).
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this study include, triethylammonium phosphate (TeaH2PO4),
triethylammonium hydrogen sulfate (TeaHSO4), triethylammonium
trifluoroacetate, (TeaTfac), triethylammonium lactate,
(TeaLa), triethylammonium triflate, (TeaTf), and triethylammonium
mesylate, (TeaMs). Since both TeaH2PO4 and TeaHSO4 have
melting points above room temperature, we measured the ThT
intensity of the Ab16-22 peptide from 97%TeaH2PO4:3%water
(v/v) through to 5%TeaH2PO4:95%water (v/v) and found that
90% TeaH2PO4 showed fast kinetics (ESI Fig. 1w). Since we
are interested in high pIL content solvents we therefore
decided to compare the kinetics of fibrilization in the above
mentioned pILs at a fixed concentration of 90%pIL:10%water
(v/v). The ThT intensity of the Ab16-22 peptide in different
pILs is shown in Fig. 1. Both TeaH2PO4 and TeaHSO4,
showed remarkably fast fibrilization with the maximum ThT
signal observed after 1 min. The kinetics of both TeaTfac
and TeaLa show a lag phase with fibrilization proceeding to
a measured maximum after several hours for TeaTfac and
2 days for TeaLa. TeaTf showed a longer lag phase with a
maximum ThT signal observed after 2 weeks. In the cases of
TeaTfac, TeaLa and TeaTf, the maximum ThT signal is less
than 1, this may indicate either the presence of aggregated
states or a different amyloid structure. Interestingly, no fibrils
formed in the 90%TeaMs solution even after 4 months,
and more importantly the solution remained clear indicating
the Ab16-22 was still in solution. No change in secondary
structure, as measured using CD, was observed over this time
period, Included in Fig. 1 is the ThT response for Ab16-22 in
phosphate buffer, which reached a maximum on day 9.
A reverse Hofmeister trend is observed when the pILs are
listed in order of fibrilization rate. That is, TeaHSO4, Tea
H2PO4, TeaTFac, TeaLa, TeaTf, and TeaMs. Traditionally,
both phosphate and sulphate are considered to be kosmotropic
anions. These anions are considered to be water structuring
and generally enhance protein stability.28 The reverse Hofmeister
trend observed here in the 90% pIL solutions suggests that
competitive hydrogen bonding between the anion of the pIL
and water is driving the self assembly of the Ab peptide into
amyloid fibrils. In this context both TeaH2PO4 and TeaHSO4
are ‘‘salting out’’ the Ab peptide and resulting in amyloid
fibrils. It also suggests that in high pIL concentration solutions
such as the ones studied here (90%pIL;10%water (v/v)), does
not completely dissociate into individual ions, and probably
ion pairs or higher order aggregates exist or the presence of
microsegregated IL phase,29,30 This would explain the deviation
from the Hofmeister series, which is often used to explain the
salting in and salting out effects of salts with respect to protein
stability and solubility.
The fast kinetics of fibrilization in 90%TeaH2PO4 confirmed
by the ThT binding experiment supports our initial observation
of white participates forming in the 90%TeaH2PO4 seconds
after the monomeric peptide is added. (ESI shows movie clip
of fibrilizationw). We then decided to examine the fibrils using
TEM, long mature fibrils were present in the solution after one
minute as shown in Fig. 2a. Fig. 2b shows an overview of the
amyloid fibrils that can be achieved after one minute in
90%TeaH2PO4. A dense highly branched network is observed.
This extremely fast fibrilization rate holds considerable
promise in the application of amyloid fibrils for biomaterials.
Fig. 3a shows the micrograph of the Ab16-22 peptide, after
1 min, in 90%TeaHSO4. This pIL also registered a maximum
ThT intensity after one minute. However, as can be seen from
the micrograph, in this case fibrils are not present, rather
spherical objects can be seen in the micrograph. The spherical
objects, are termed annular oligomers.31 The formation and
stabilization of annular oligomers is an important finding as it
has been suggested that annular oligomers may be wholly or
partly responsible for the cytoxicity associated with the formation
of amyloid fibrils.11,30 The annular oligomers are stabilized by
the TeaHSO4 pIL for 2days after which small fibrils can be
seen, however some spherical objects are still present (Fig. 2b).
The presence of the annular oligomers and amyloid fibrils in
the same solution supports the complexity of amyloid
fibrilization process and why pinning down the toxic confor-
mation is difficult.
Fig. 4 shows the CD spectrum of Ab16-22 for 90%Tea-
HSO4 and 90%TeaMs. Given the difference in fibrilization
kinetics observed in the pIL solutions we measured the CD
spectrum of Abeta in 90%TeaHSO4 and 90%TeaMs.
Fibrilization in 90%TeaHSO4 occurs on the time scale of
minutes whereas no fibrilization is observed in 90%TeaMs.
Interestingly the conformation of the peptide in both these
solutions is very similar. The similarity of the CD spectrum,
which represents an extended 310helix,32 suggests that the
Fig. 2 TEM images shows amyloid fibrils of the Ab–22 in
90%TeaH2PO4 at 1 min and (b) overview of (a) showing a dense
amyloid network after 1 min. Scale bar 200 nm.
Fig. 3 TEM images showing amyloid fibrils of Ab16-22 in

























































16536 Phys. Chem. Chem. Phys., 2011, 13, 16534–16536 This journal is c the Owner Societies 2011
initial conformations, for the Ab16-22 peptide in both these
solutions is similar. This further suggests that the anion-water
interactions of the pIL is the driving force for the differences
observed in the fibrilization kinetics.
We have shown that the kinetics of fibrilization for Ab16-22
can be tuned by following a reverse Hofmeister strategy in pIL
solutions using the triethylammonium cation. Fibrilization
can be both accelerated or completely suppressed depending
on pIL choice. This has potential impact in understanding the
underlying process of amyloid fibrilization. Additional, the
ability to create fibrils on the time scale of seconds is important
from a biomaterials aspect. The use of amyloid fibrils to create
nanostructures is a promising avenue of research33 and the
ability to accelerate fibrilization is beneficial in this context.
The kinetics of fibrillization shown here follows a reverse
Hofmeister trend. When pILs contain kosmotropic anions
such as phosphate the rate of amyloid fibrilization is increased,
in a ‘‘salting out’’ scenario, while pILs containing mesylate
anions suppress amyloid fibril formation, in a ‘‘salting in’’
scenario. One possible explanation for this observation is that
strong anion–water interactions are driving the self assembly
process. The structure of water involves ice-like structure
pools and disordered zones. The addition of highly ordered
anions such as phosphate or sulfate may cause the disordered
zones to become more ordered as a result of H-bonding
between the anion and water, resulting in an increase in the
volume occupied by the ions. This competitive H-bonding
between the water and the anion may, in the protic ionic liquid
case, be driving the self assembly of the Ab16-22 into amyloid
fibrils.
The stabilization of annular oligomers is an important
finding and future work is aimed at investigating the
neurotoxicity of the ionic liquid stabilized states and the ability
for ionic liquids to reverse the aggregation process of amyloid
fibrils from the Ab16-22 peptide.
Conclusions
We reported the fibrilization kinetics and superstructure
organization of the Ab16-22 peptide in a series of protic ionic
liquids (pIL). The kinetics of Ab16-22 fibrilization follows a
reverse Hofmeister trend. We find that pILs containing
kosmotropic anions like phosphate or sulphate promote
fibrilization with mature fibrils forming within seconds whilst
pILs containing the mesylate anion completely suppresses
amyloid fibrilization. The self assembly and superstructure
organization of the amyloid fibrilization process was also
found to be influenced by pIL composition, resulting in the
stabilization of annular oligomers, a key intermediate state.
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